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1. Summary 
 
 
Infection of pigs with PCV2 is associated with several diseases. The onset of the viral 
infection is not clear but may occur in utero and may be prevented by vaccination of 
dams. In this study we determined the prevalence and load of PCV2 protein and DNA in 
tissues of fetuses obtained from non-vaccinated or vaccinated healthy dams. Also, sera 
from these piglets and from the dams were collected for PCV2-specific antibody 
determination. We analysed 91 fetuses of 7 naïve dams, 58 fetuses of 4 dams 
vaccinated with Ingelvac® CircoFLEXTM and 94 fetuses of 6 dams vaccinated with 
Circovac®. In none of the fetal tissues macroscopic or histopathological alterations 
were found. All tissues investigated randomly by immunohistochemistry for the 
presence of PCV2 protein were negative. To detect viral DNA, various tissues were 
analysed by fluorescence in situ hybridisation. All thymi, 91% of the mesenteric lymph 
nodes, 60% of the Peyer’s patches of the ileum and 24% of the spleen were PCV2 DNA 
positive. Fetuses of some vaccinated dams had a significantly lower PCV2 DNA load. 
All fetal sera were negative for anti-PCV2 IgG and IgM antibodies whereas sera from 13 
dams tested contained anti-PCV2 IgG antibodies. Sera of 16 dams were negative for 
anti-PCV2 IgM antibodies indicating recent infection. In none of the fetal tissues 
analysed PCV2 specific proteins were detected, whereas at least on fetal tissue was 
positive for PCV2 DNA irrespective of the vaccination status of the dam. Hence, the 
viral load but not the prevalence of viral infection may be influenced by vaccination. 
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2. Introduction 
 
 
Infections with porcine circovirus type 2 (PCV2) can cause several disease 
manifestations in pigs, named porcine circovirus associated disease (PCVAD) which 
includes postweaning multisystemic wasting syndrome (PMWS), porcine dermatitis and 
nephritis syndrome (PDNS), porcine respiratory disease complex (PRDC), proliferative 
necrotising pneumonia (PNP), granulomatos enteritis in weaned pigs, necrotising 
lymphadenitis and also reproduction problems [1]. PMWS was first described by 
Harding and Clark in 1997 [2]. Since then, PMWS has emerged worldwide and is one of 
the economically most important swine diseases [3, 4]. 
PCV2-associated reproductive failure in dams was first reported in 1999 [5] and since 
then repeatedly described by other research groups [6-8]. Clinical manifestations of 
reproductive failure vary among farms and gestation stage including mummification, 
abortion, stillborn or weak-born piglets, delayed farrowing [6] and pseudopregnancy [9]. 
Reproductive disorders are more often observed in gilts and newly established herds [5, 
7, 9]. Pathological findings in PCV2 infected fetuses can show gross lesions as 
pulmonary edema, hepatomegaly and ascites as well as histological myocardial 
necrosis and fibrosis [5]. According to Segalés et al. [10], diagnosis of PCV2-associated 
fertility disorders is based on the fulfilment of three criteria: (I) clinical signs such as late-
term abortions and increased numbers of stillbirths, mummified fetuses or weak-born 
piglets, (II) microscopical lesions such as myocardial lesions like fibrosing and/or 
necrotising myocarditis and (III) the presence of plenty of PCV2 antigen or DNA in the 
lesions. 
Particular high concentrations of PCV2 antigen are readily visible in dead fetuses by 
immunohistochemistry (IHC) [5, 7, 8, 11, 12]. However, in healthy viable neonatal 
piglets PCV2 infection can also be demonstrated by either PCR and/or serum anti-
PCV2 antibodies. Interestingly, Shen et al. [13] found DNA of PCV2 in serum of 
newborn piglets in 40% before colostrum intake and 21.4% were positive for anti-PCV2 
IgG antibodies. 
Horizontal PCV2 infection is thought to be the main route of virus transmission [14, 15]. 
However, there are also reports about vertical transmission from the parents to progeny 
either through the placental barrier [5, 12], through a pre-existing infection of the dam’s 
reproductive tract [16] or via an infection of gametes, mainly through semen [17]. 
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Vaccination against PCV2 almost eliminated the occurrence of PCVAD and improves 
mortality rates of nursery and fattening pigs as well as pig performance in farms, 
chronically infected with PCV2 [18]. Although vaccination against PCV2 reduces 
viremia, PCV2 DNA was still detected in colostrum and piglets from vaccinated dams by 
sensitive PCR [19]. 
In Switzerland reproduction failure due to PCV2-infection was first described in 2008 
[20]. However, a prevalence-study of 286 fetuses of 113 dams from 59 farms with 
anamnestically increased reproductive disorders, before nationwide vaccination against 
PCV2, revealed only 4% PCV2-associated fertility disorders, fulfilling the case definition 
criteria, in particular a high amount of PCV2 antigen visible by IHC [11]. However, by 
PCR and fluorescence in situ hybridisation (FISH) most fetuses harboured PCV2 DNA 
in small amounts (manuscript in preparation). In this study thymus was found to be the 
organ with the highest and most abundant PCV2 infections. Thus, we have evidence 
that fetal infections are more common than originally thought, even though most fetuses 
are inconspicuous by anti-PCV2 IHC.  
Despite thymus atrophy is a common lesion in PMWS, thymus involvement in PCV2 
infected piglets and fetuses is only sporadically mentioned in literature [21-26]. 
Interestingly, chicken anemia virus (CAV), a Gyrovirus, which belongs to the family of 
Circoviridae like PCV2, is also transmitted vertically independent of the antibody status 
in chicks [27]. Both are single stranded DNA viruses with a double stranded DNA 
isoform during viral replication [28]. CAV DNA could be detected in blastodisks and 
semen of antibody positive and negative chickens [27]. The lymphoid organs and 
gonads had the highest incidence of CAV DNA. In young chickens thymus atrophy 
occurs analogous to PMWS [29]. 
The aims of this study were first to research high prevalence probability of PCV2 
infected fetuses from slaughter dams in late undisturbed pregnancy with special 
attention to primary (thymus) and secondary lymphatic organs and second to 
investigate the effect of dam vaccination on the occurrence of fetal infections with 
PCV2. 
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3. Materials and methods 
 
 
3.1. Animals and herds 
 
243 fetuses of 17 dams with undisturbed late pregnancy (dams were in 2.-11. gestation) 
from 7 different breeding farms without a farm history of increased reproductive 
problems were investigated in this study. Dams of different gestation stages (77–109 th) 
of 7 farms without PCV2 related problems were purchased and immediately after 
slaughter hysterectomized. Our study was carried out according to Swiss Animal 
Welfare guidelines (study number 202/2010). 5 dams were naturally and 12 were 
artificially inseminated. The control group included 91 fetuses of 7 dams from 3 different 
farms without PCV2 vaccination. 58 fetuses of 4 dams of 2 different farms were 
vaccinated with Ingelvac® CircoFLEX™ (baculovirus expressed subunit vaccine, 
Boehringer Ingelheim GmbH) 1 to 4 weeks before insemination (a single shot vaccine) 
and these fetuses were accounted to the FLEX-group. One dam in the FLEX-group was 
immunized just before every insemination. The CVac-group included 94 fetuses of 6 
dams from 3 different farms vaccinated with Circovac® (inactivated PCV2-vaccine with 
paraffin adjuvans, MERIAL) with a basic immunisation before first mating and a booster 
between the 50th and the 95th day of gestation. For further analysis, we splitted the 
FLEX-group and the CVac-group into the SVac-group, where dams were vaccinated 
once, and into the MVac-group, where dams received more than one immunization. In 
every farm, except for one, the piglets were additionally vaccinated against PCV2 either 
with Ingelvac® CircoFLEX™ or Circovac® at about 3 weeks of age. Table 1 shows a 
summary of litter characteristics and reproduction parameters of the groups. 
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Table 1: Experimental groups, animals and management of reproduction 
 
Groups Dam Farm Vaccination Management Litter Gestation Number of fetuses 
Mummified 
fetuses 
Control 
1 4 None natural breeding 2 104 10 2 
2 1 “ insemination 5 98 10 0 
3 1 “ “ 6 99 10 0 
4 2 “ “ 5 102 20 0 
5 2 “ “ 3 102 15 0 
6 2 “ “ 4 101 14 0 
11 4 “ natural breeding 1 77 12 2 
FLEX 
7 2 SVaca insemination 7 99 16 1 
8 2 “ “ 6 99 16 1 
9 2 “ “ 9 100 13 0 
10 3 MVacb “ 7 107 13 3 
CVac 
12 5 MVac insemination 10 104 8 1 
13 5 “ “ 6 98 17 0 
14 6 “ “ 6 109 12 0 
15 6 “ natural breeding 7 109 19 0 
16 7 “ “ 5 104 21 0 
17 7 “ “ 6 105 17 0 
 
Experimental groups, dam and farm identification number, management of 
reproduction, number of previous litters of dams, gestation (days), number and 
mummified fetuses are shown. For the grouping of FLEX and CVac see material and 
methods. 
a SVac: single vaccination 
b MVac: multiple vaccinations 
 
 
3.2. Tissue and blood sampling 
 
Serum and blood samples were individually collected from dams and fetuses. Fetuses 
were taken out of the gravid uteruses and blood was collected immediately by heart 
puncture. Serum samples were centrifuged at 3600g for 10 minutes and then all blood 
and serum samples were stored at -20°C until examination. Tissue samples from 
thymus, spleen, mesenteric lymph nodes, ileum, heart, liver, lung, bone marrow and 
placenta were collected at necropsy and fixed in 4% formalin for histological 
examination and for FISH evaluation of thymus, spleen, mesenteric lymph nodes and 
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Peyer’s patches of the ileum. Also IHC was performed on the same tissue samples from 
randomly selected fetuses. 
 
 
3.3. Histopathology 
 
The formalin fixed tissues were embedded in paraffin wax one day after sampling. 
Sections of 2-3 μm were stained with hematoxylin and eosin by standard methods. All 
the collected organs were evaluated for the presence of histological lesions. 
 
 
3.4. Fluorescence in situ hybridisation (FISH) 
 
Tissue samples of thymus, spleen, mesenteric lymph nodes and ileum were fixed and 
paraffin-embedded. We used the DISCOVERY instrument (Ventana Medical System) 
for staining the slides and the experimental protocol was run with help of the 
DISCOVERY software. 
In short, the slides were first deparaffinised with EZ Prep (Ventana Medical System) for 
28 min and pre-treated for 4 min with Protease I (Ventana Medical System) at 37°C. 
Tissue sections were overlaid with corresponding 5’ and 3’ fluorescents labeled 
oligonucleotide probes after denaturizing for 4 min at 90°C. Hybridization lasted for 2 h 
at 37°C. Slides were washed in two stringency washes at 47°C for 4 min. Afterwards 
samples were treated with a 4% fixative reagent for 24 min to fix oligonucleotide probes 
to the target DNA. After two washing steps tissue sections were counterstained. Finally, 
slides were washed and mounted with FloureGuard Mounting Medium (Scy Tec). In 
every run we carried along a slide with a positive and a negative control. 
For signal detection we used a Leica DMLB IF fluorescence microscope. Pictures were 
taken by Bonn Tec Imaging. To estimate the signal detection in the organs we used a 
score from 0 (negative, no cells were positively labeled), 1 (a very small number were 
positive labeled), 2 (slightly positive labeled cells), 3 (moderately positive labeled cells) 
to 4 (profoundly positive labeled cells).  
PCV2 infected cells in thymus were arranged either in groups or solitarily distributed. 
Therefore we counted positive cells which occurred in groups or singly and compared 
the distribution between the groups. 
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To make the infection intensity of the four organs over all fetuses visible we used a 
score system from 0 to 4 based on the scale described above.  
To differentiate between ssDNA and dsDNA we used the experimental protocol as 
described in Khaiseb et al. [30]. For signal detection a Leica SP5 Mid UV-VIS laser 
confocal scanning microscope at the Center for Microscopy and Imaris 7.3 image 
analysis software (University of Zurich, Switzerland) was used. 
 
 
3.5. Immunohistochemistry (IHC) 
 
From fixed and paraffin-embedded tissue we randomly selected 20 fetuses with highly 
infected thymus (score 3 or 4) determined with FISH and all mummified fetuses. We 
used the F217 monoclonal anti-PCV2 antibody for immunohistochemistry [31]. Tissue 
sections were first deparaffinised and incubated with pronase (S2019, Dako, Glostrup, 
Denmark) for 60 min, then rinsed with Tris-buffered saline containing Tween-20 
(TBS/T20) (Wash Buffer 10x, S3006, DakoCytomation) and F217 monoclonal antibody 
supernatant was diluted 1:2 and then incubated for 60 min with tissue sections. After 
neutralizing the endogenous peroxidase activity (Peroxidase-Blocking Solution, S2023, 
DakoCytomation), the slides were washed with TBS/T20 and incubated with secondary 
dextran-bound peroxidase-conjugated goat anti-mouse/rabbit antibody (Envision-Kit 
Mouse K500, DakoCytomation) for 30 min. 10 min of substrate (amino-ethyl-carbazol 
(DakoCytomation)) conversion was given to detect specific antigen-antibody reaction. 
Afterwards, tissue sections were counterstained with haematoxylin. The 
immunohistochemical reactions were carried out in the DakoCytomation Autostainer at 
room temperature. 
 
 
3.6. Serological examinations 
 
A competitive enzyme-linked immunosorbent assay (SERELISA® PCV2b Ab Mono 
Blocking, SYNBIOTICS EUROPE SAS 2, Lyon, France) was used for anti-PCV2 IgG 
antibody detection according to manufacturer’s instructions and a published reference 
[32]. Additionally, we supplemented the ELISA assay with internal controls, an 
additional positive and negative control serum to check the homogeneity of the plate 
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antigen coating as well as another known pig serum on each plate to normalize S-
values amongst individual plates [18]. For calculation we used a ready-to-use Excel-
sheet provided by SYNBIOTICS EUROPE SAS. We evaluated every S-value higher 
than 2000 EU as a positive result (internal experience).  
Anti-PCV2 IgM antibodies were measured using INGEZIM Circovirus IgG/IgM 
(Ingenasa, Madrid), a captured immunoenzymatic assay specific for IgM antibody 
detection to PCV2. As in the manufacturer’s instruction written we interpreted an O.D. 
higher than 0.7 as positive and an O.D. lower than 0.3 as negative. 
 
 
3.7. Real-time PCR made visible with SYBR Green 
 
We used a real-time PCR based SYBR Green method to determine blood PCV2 DNA 
template concentrations of dams and fetuses. DNA was extracted with the help of 
MagNA Pure LC DNA Isolation Kit II (Tissue) (Roche Diagnostics GmbH, Roche 
Applied Science, Mannheim, Germany, Version December 2005). In each separate 
PCR run we used predefined 5 different 10 PCV2 DNA template concentration 
increases of recombinant PCV2 sequence. In the real-time PCR we used a master mix 
supplemented for each reaction with 12.5 μl Sybr Green 2x and 20 μM oligonucleotides 
(PCV2 F, 5’-CGY TGG AGA AGG AAA AAY GGC and PCV2 R, 5’-GTA GTA TTC AAA 
GGG YAY AGA G). The real-time PCR was run on an ABI Fast 7500. Cycling 
parameters were 50°C for 2 min, 95°C for 10 min, 50 cycles of 95°C for 15 s, 62°C for 
30 s and 65°C for 45 s followed by PCR reaction product dissociation at 95°C for 15 s, 
60°C for 1 min and 95°C for 15 s. As negative controls several PBS, bovine serum and 
water samples were carried along each PCR run. PCV2 positive samples dissociation 
parameters were in the range of 78.3°C to 81.7°C.  
 
 
3.8. PPV-diagnostic 
 
In order to exclude a porcine parvovirus (PPV) infection a tissue homogenate from 
mummified fetuses, consisting of heart, lung, liver and kidney, underwent an 
examination by real-time PCR [33] or by indirect immunofluorescence (IIF) [34] 
depending on the crown-rump length of the fetus. 
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3.9. Statistical analysis 
 
The R statistical software environment (R Core Team 2012) was used for all data 
modeling. Due to the potential for correlated observations (multiple observations from 
within the same dam, and dams nested within farms) generalized linear mixed models 
were utilized using the lme4 and nlme extensions packages for R. Akaikes Information 
Criterion (AIC) was used to choose an optimal form of random effects to account for 
correlations between observations. The chosen form of statistical model was then used 
to estimate the statistical significance of the effect of factors of interest, such as type 
and frequency of vaccination, through a standard likelihood-ratio test between the 
different groups. P-value of ≤ 0.05 was accepted as statistically significant. 
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4. Results 
 
 
4.1. Clinical examination, reproduction parameters of dams and post-mortem 
examination of fetuses 
 
All sows were clinically healthy at the time of slaughter. Necropsied fetuses had no 
macroscopic or histological lesions. Four mummified fetuses were found in two dams of 
the control group, five mummified fetuses from three different sows of two different 
farms and one mummified fetus were found in the FLEX- and CVac-group, respectively. 
All mummified fetuses were tested negative for PPV. Based on earlier results from IHC 
negative aborted fetuses (manuscript in preparation) we assume that all fetuses without 
lesions were PCV2 antigen negative. To confirm this hyothesis, we tested 20 randomly 
selected fetuses. All mummified fetuses as well as the 20 selected fetuses were tested 
negative for PCV2 antigen by IHC. 
 
 
4.2. PCV2 antibodies in fetuses and dams 
 
All examined fetuses had no detectable anti-PCV2 IgG and IgM antibodies. In the 
control group four sows had positive anti-PCV2 IgG antibody titers and three sows were 
negative for anti-PCV2 IgG antibodies (<2000 EU). The mean antibody titer in the 
control group was 8’784 EU. In the FLEX-group all dams had positive IgG antibody 
titers with an average titer of 57’505 EU and in the CVac-group five from six sows had 
positive anti-PCV2 IgG antibody titers with a mean value of 129’115 EU. However, one 
sow was repeatedly negative for anti-PCV2 antibodies. The average antibody titer from 
the SVac-group was 66’067 EU in comparison to the mean antibody titer of 115’215 EU 
from the MVac-group. 
All sows of the CVac-group, except one, with a repeatedly, doubtfully positive result, 
were negative for anti-PCV2 IgM antibodies. Table 2 summarizes the results for anti-
PCV2 IgG and IgM antibodies. 
 
 
 
  12 
 
Table 2: PCV2-specific serum antibody and PCV2 PCR results. 
 
Groups Dam 
 
Dam IgG Fetal IgG Dam IgM Fetal IgM Dam PCR Fetal PCR 
Control 
1  1 0/10 - 0/10 n.d.a 0/10 
2  4846 0/10 - 0/10 - 1/10 
3  384 0/10 - 0/9 - 0/10 
4  17191 0/20 - 0/20 - 0/20 
5  5573 0/15 - 0/15 - 0/15 
6  33452 0/14 - 0/14 - 1/14 
11  43 0/12 - 0/12 - 0/12 
FLEX 
7  70055 0/16 - 0/16 - 0/16 
8  40571 0/16 - 0/16 - 0/16 
9  87576 0/13 - 0/13 - 0/13 
10  31819 0/13 - 0/13 - 0/13 
CVac 
12  950 0/8 - 0/8 - 0/8 
13  494438 0/17 - 0/17 + 1/17 
14  3031 0/12 - 0/12 - 0/11 
15  148331 0/19 - 0/19 - 1/19 
16  84459 0/21 +/- 0/21 - 1/21 
17  43480 0/17 - 0/17 - 2/17 
 
Serum IgG antibody titers are shown as ELISA units, whereas fetal IgG and IgM specific 
to PCV2 and the PCR results are the numbers of positive results/group. All PCRs 
performed with sera resulted rarely and in slightly positive amplifications. 
an.d.: not done 
 
 
4.3. PCV2 viremia in fetuses and dams 
 
Only in a few fetuses (2.9%) low concentrations of PCV2 DNA were detected in fetal 
blood by real-time PCR. Namely, in 2 fetuses from two different sows of the control 
group and in 5 fetuses from 4 different sows of the CVac-group. All fetuses from the 
FLEX-group had no detectable PCV2 DNA (table 2). The concentrations of PCV2 DNA 
in fetal blood ranged from 1.5x105 genome copies/ml to 6.5x105 genome copies/ml. 
Only in one sow of the CVac-group 1.3x105 genome copies/ml of PCV2 were detected. 
Blood from one sow in the control group was not available (table 2). 
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4.4. Prevalence of PCV2 infection and comparison of virus load in thymus, spleen, 
mesenteric lymph nodes and Peyer’s patches of the ileum evaluated by FISH 
 
PCV2 infection prevalence of fetal organs was as following: 242 of 242 examined 
fetuses (100% prevalence) contained PCV2 DNA containing cells in the thymus. 
Thymus of one fetus was not available. 217 of 238 examined mesenteric lymph nodes 
(91% prevalence) harbored PCV2 DNA, 127 of 212 were positive in Peyer’s patches of 
the ileum (60% prevalence) and 58 of 241 examined fetuses had FISH positive cells 
(24% prevalence) in the spleen. The prevalence of fetal organ infections and the 
detailed distribution is shown in table 3. There was a significant difference in the 
prevalence of PCV2 infection between the investigated primary and secondary 
lymphatic organs calculated over all groups. Spleen was significantly less often infected 
than the Peyer’s patches of the ileum which was itself significantly less often infected 
than the mesenteric lymph nodes. However, indeed statistically not calculable due to a 
zero occurrence of negative infection, thymus was obviously the most infected organ 
(figure 1). 
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Fig. 1: Prevalence and intensity of PCV2 DNA in thymus, mesenteric lymph nodes, 
ileum and spleen. We calculated the p-values for intensity between organs with a cut 
off, which compared not or low infected organs with high infected organs of fetuses. To 
make the intensity graphically visible we used a score system.  
 
 
Infection prevalence of an organ was one criteria and virus load in a specific organ was 
another parameter. To estimate virus load differences of a particular organ between the 
investigation groups by the categorized data analysis from score 0 to 4, we set a cut off 
between not or low and higher infected fetuses individually for each organ. Of note, 
thymus showed no differences in PCV2 DNA load among the control-, the FLEX- and 
the CVac-group (p=0.1069). Also, there were no significant differences between the 
control group and the two combined vaccination groups (p=0.6672) considering PCV2-
DNA infected thymus cells. However, we found significant differences between the 
control-, the SVac- and the MVac-group (p=0.0124), with the SVac-group containing 
less PCV2 DNA positive cells than the other groups. A histogram of the five groups in 
thymus is shown as an example in figure 2. It was not possible to calculate the 
significance between the control-, the FLEX- and the CVac-group in mesenteric lymph 
nodes due to zero degree in the data set. However, table 3 shows a PCV2 infection 
reduction in the FLEX-group in mesenteric lymph nodes. There was no significant 
difference between the control group and the both combined vaccination groups 
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(p=0.3226), but between the control-, the SVac- and the MVac-group (p=0.0027). The 
SVac-group containes less positive cells in mesenteric lymph nodes then the other 
groups. Peyer’s patches of the ileum from the control group (p=0.0217) were 
significantly less infected than the Peyer’s patches of both combined vaccination groups 
together. Again, it was not possible to calculate the significance between the control-, 
the FLEX- and the CVac-group due to zero degree in the data set. The MVac-group 
(p=0.0326) has significantly more positive cells in Peyer’s patches of the ileum then the 
control- and the SVac-group. Spleen was the lowest infected organ in our 
investigations. Nevertheless, we found significant differences in the comparisons 
between the control-, the FLEX- and the CVac-group (p=0.0016), with the CVac-group 
having less positive cells in the spleen. Also the combined vaccination groups 
(p=0.0010) have significantly less positive cells in spleen than the control group. The 
MVac-group (p=0.0008) has significantly less positive cells inside compared to the 
control- and the SVac-group. 
 
 
 
 
Fig. 2: Comparison of PCV2 DNA intensity between groups of thymal tissues. We 
compared the groups due to a cut off between low (1 / 2) and high (3 / 4) positive thymal 
tissues. SVac-group has significantly less high infected thymus (p=0.0124) than control- 
and MVac-group. 
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The differences in PCV2 DNA load between the organs were calculated by comparing 
the highly infected organs between each other. Therefore we set an individual cut off 
between low and high infection for every single organ. Thymus was not only the most 
often infected organ, it contained also the highest concentration of PCV2 genomes 
followed by mesenteric lymph nodes, Peyer’s patches of the ileum and spleen. To make 
this graphically visible we used a score system (figure 1). Though PCV2 DNA is readily 
measurable, virus antigen was not detected by IHC. This is different in fetuses which 
died of a PCV2 infection. 
 
 
Table 3: Frequency and quantity of PCV2 DNA in different fetal tissues.  
 
Tissue FISH Control       
n (%)a 
FLEX        
n (%)a 
CVac         
n (%)a 
SVac        
n (%)a 
MVac         
n (%)a 
Total         
n (%)a 
Thymus 
N=242 
0 0 0 0 0 0 0 
1 0 1 (2) 2 (2 ) 0 3 (3) 3 (1) 
2 19 (21) 21 (37) 11 (12) 21 (48) 11 (10) 51 (21) 
3 59 (65) 35 (61) 66 (70) 23 (52) 78 (73) 160 (66) 
4 13 (14) 0 15 (16) 0 15 (14) 28 (12) 
Mesenteric 
lymph node 
N=238 
0 6 (7) 2 (3) 13 (14) 2 (4) 13 (12) 21 (9) 
1 45 (51) 56 (97) 32 (35) 43 (96) 45 (43) 133 (56) 
2 24 (27) 0 25 (27) 0 25 (24) 49 (21) 
3 13 (15) 0 21 (23) 0 21 (20) 34 (14) 
4 0 0 1 (1) 0 1 (1) 1 
Ileum 
N=212 
0 38 (62) 31 (53) 16 (17) 26 (58) 21 (20) 85 (40) 
1 23 (38) 27 (47) 65 (70) 19 (42) 73 (69) 115 (54) 
2 0 0 12 (13) 0 12 (11) 12 (6) 
3 0 0 0 0 0 0 
4 0 0 0 0 0 0 
Spleen 
N=241 
0 42 (47) 50 (86) 91 (98) 37 (82) 104 (98) 183 (76) 
1 48 (53) 8 (14) 2 (2) 8 (18) 2 (2) 58 (24) 
2 0 0 0 0 0 0 
3 0 0 0 0 0 0 
4 0 0 0 0 0 0 
 
Tissues of the different organs listed and derived from animals of the control-, FLEX- 
and CVac-groups were analyzed by FISH and arbitrarily scored from 0-4 for the quantity 
of PCV2 positive cells present. The vaccinated animals were further grouped as single 
vaccinated (SVac) or multiple vaccinated (MVac). The total absolute and relative 
number of events in a given tissue was also calculated (Total). 
a
 n(%): absolut and relative number (given as %) of tissues scored as indicated 
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4.5. Analysis of distribution patterns of FISH positive cells in thymus 
 
In thymus we found two different distribution patterns. Either the positive cells were 
accumulated in clusters (figure 3a) or they were individually distributed (figure 3b). We 
always found both patterns in thymus in different proportions. We evaluated the 
distribution patterns of infected cells by estimating the percentage of positive cells to be 
present in clusters or individually arranged. The results are shown in table 4. In 
summary, the FLEX-group (p=0.310) contained significantly higher proportions of 
infected cells present in clusters than the control-, the CVac-, SVac- or the MVac-group. 
 
 
Table 4: Frequency and distribution patterns of PCV2 positive cells in thymi. 
 
  Control FLEX CVac SVaca MVacb 
 Score 
Single 
n (%) 
Aggregated 
n (%) 
Single 
n (%) 
Aggregated 
n (%) 
Single 
n (%) 
Aggregated 
n (%) 
Single 
n (%) 
Aggregated 
n (%) 
Single 
n (%) 
Aggregated 
n (%) 
1 0 0 0 1 (2) 0 2 (2) 0 0 0 3 (3) 
2 7 (8) 12 (13) 8 (14) 13 (22) 7 (7) 4 (4) 8 (18) 13 (29) 7 (7) 4 (4) 
3 36 (40) 23 (25) 4 (7) 31 (53) 41 (44) 25 (27) 3 (7) 20 (44) 42 (39) 36 (34) 
4 9 (10) 4 (4) 0 0 6 (6) 9 (10) 0 0 6 (6) 9 (8) 
Sub-
total 52 (57) 39 (43) 12 (21) 45 (77) 54 (57) 40 (43) 11 (25) 33 (73) 55 (51) 52 (49) 
Total  91 (100) 57 (98) 94 (100) 44 (98) 107 (100) 
 
PCV2-positive cells in thymus of animals of the control-, FLEX- or CVac- vaccinated 
groups appeared as single cells (single) or as cell aggregates (aggregated). The events 
were arbitrarily scored as absolute (n) and relative (%) numbers as shown in table 3. 
a
 SVac: singly vaccinated dams 
b
 MVac: dams vaccinated multiple time  
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Fig. 3a: PCV2 positive cells Fig. 3b: PCV2 positive cells arranged  
in clusters pictured with FISH. free pictured with FISH. 
 
 
4.6. Existence of replicative forms of PCV2 in thymus 
 
To identify virus propagation potential in the slightly infected fetuses we evaluated some 
thymus sections for the presence of single and double strand PCV2 genomes by FISH. 
Indeed, we found double stranded DNA in thymus (figure 4a and 4b) indicating PCV2 
propagation in this organ.  
 
 
   
 
Fig. 4a: The green labeled cells show  Fig. 4b: In red only dsDNA is visible by 
ssDNA together with dsDNA by FISH.  FISH. 
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5. Discussion 
 
 
Previously, we reported marked improvement of production parameters with vaccination 
against PCV2 of dams in farms subclinically infected with PCV2 [18]. Additionally, we 
found fetal thymus of pigs to be persistently, even latently infected with PCV2 DNA 
(manuscript in preparation). These observations led us to the assumption whether the 
internal, lymphatic viral pools might be reduced by vaccination and thus, might explain 
the improvement of production parameters by anti-PCV2 vaccination. We evaluated 
primary and secondary lymphatic organs from PCV2 IHC negative, immune-competent 
fetuses by FISH. We detected positive cells in thymus in 100% of the examined fetuses 
and also in other lymphatic organs but with lower prevalence. Thymus was not only the 
most often infected organ but also the organ with the highest PCV2 infection density. 
After vaccination, these PCV2 infection distributions hardly changed in thymus. 
However, in mesenteric lymph nodes we found a reduced prevalence of PCV2 DNA 
infection after one vaccination. In thymus a change of infection pattern formation could 
be found in the FLEX- and the SVac-group. Nevertheless, after multiple vaccinations 
these internal virus pools leveled out to the levels of fetal organs from non-vaccinated 
sows in reference to virus prevalence, intensity and pattern formation. 
Surprisingly, the thymus is described in PMWS as atrophic and yet, in most studies, 
thymus was neglected. Exceptions are in animal infection experiments when the organs 
of the pigs were flooded with PCV2. For example in a study with dams infected 
intranasally at late gestation, their fetuses harbored PCV2 genomes in thymus [12]. 
However, these piglets had lesions due to the PCV2 infection and were highly PCV2 
antigen positive in the majority of cases. Another recent study detected PCV2 DNA with 
a prevalence of 39.9% and anti-PCV2 IgG antibodies in 21.4% of neonatal pig blood 
before their first colostrum intake from clinically normal swine breeding herds [13]. 
Baker et al. [35] reported a PCV2 prevalence of 0% to 20% in their pigs. However, in 
this study older sows had more viremic piglets than younger sows. These might be 
indications that neonates carried PCV2 even before birth. 
In contrast, we only detected PCV2 DNA in the blood of seven fetuses (2.9%) and none 
had a meaningful immune response in form of anti-PCV2 IgM or IgG antibodies. This 
less than 3% of infected blood from fetuses compared with the 39.9% in the other study 
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might be accounted to different PCV2 infection pressures on the farms or simply 
differences in the effectiveness of methodology. 
We were not able to detect either anti-PCV2 IgM or anti-PCV2 IgG antibodies in any 
fetuses. Particularly, we also did not detect PCV2 specific antibodies in fetuses 
containing PCV2 DNA in serum. Possible reasons for the deficiency of PCV2 specific 
antibodies could be the low presence or absence of PCV2 capsid protein, or that PCV2 
infection occurred before the 57th day of gestation when fetuses are still immune-
incompetent. In experimental infections of pregnant dams before the 57th day of 
gestation, fetuses did not produce any PCV2 specific antibodies [8]. Infections after day 
57 induced antibodies in the now immune-competent pig fetuses [8]. These results 
correlated with another study where other antigens did induce an immune response in 
pig fetuses only after 58th day of gestation [36]. The argument of the early fetuses’ 
infections with PCV2 gets also supported by the observation that semen [37, 38] or 
oocytes in the reproduction tract can carry PCV2 [16]. Additionally, PCV2 was able to 
infect zona pellucida-free morula and early blastocysts [39]. Therefore, PCV2 has the 
potential to infect embryos in the earliest stages of gravidity. It is also interesting to 
notice that chicken anemia virus (CAV), a family member of the Circoviridae infects 
chicken oocytes and stays latent until reactivation [27, 40]. Similar to our findings that 
PCV2 infects the thymus of pig embryos, CAV is also known to infect chicken thymus 
[29, 41, 42]. Comparable to latent infections with CAV, we did not find any anti-PCV2 
antibodies in pig fetuses although we abundantly detected PCV2 genomes and also the 
replicative PCV2 isoform that makes a low replication of PCV2 plausible. Further 
investigations are needed to understand more about PCV2 latency and what effect this 
might have on the health status of individual pigs. 
To determine whether sow vaccination might reduce the latent form of PCV2 in fetuses 
we compared embryos from vaccinated dams to embryos from non-vaccinated mothers. 
Many reports describe a direct effect of anti-PCV2 immunization of dams or piglets, for 
example in reduced mortality rate [43] or improved production parameters [44-47]. 
Subsequently, anti-PCV2 vaccinated dams, after challenge with PCV2, showed reduced 
PCV2 propagation in utero most probably because of their own reduced PCV2 viremia 
[19]. However, the vaccination did not prevent fetal PCV2 low-level viremia. 
Nevertheless, PCV2 antigen was absent in tissues of these neonates [19]. Another 
report by the same research group suggested that dam-associated PCV2 specific 
antibodies are not protective for in utero PCV2 infection [48]. Although, these data are 
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very reasonable and important they have to be judged with caution. As these authors 
were most probably not aware of the latent PCV2 characteristics they additionally 
infected test animals with PCV2, whereas we compared preexisting endogenous PCV2 
levels. We used an advanced oligonucleotide mediated FISH to detect PCV2 DNA in 
tissues of fetuses. We found no obvious distinction between the control-, the FLEX- and 
the CVac-group in matters of prevalence and intensity of positive cells in thymus. 
Statistically significant differences could be found between groups in mesenteric lymph 
nodes, Peyer’s patches of the ileum and spleen. However, pig groups responded to 
vaccination differently in every organ: for example vaccination had no real beneficial 
effect for clearing PCV2 infection in Peyer’s patches of the ileum. This was different in 
mesenteric lymph nodes or spleen. In spleen, vaccination in general reduced PCV2 
infection and in mesenteric lymph nodes single vaccination was effective in reducing 
endogenous pre-existing PCV2 concentrations. Interestingly, when we compared 
pattern formation of PCV2 infected cells of thymus we detected less freely arranged 
PCV2 infected cells in the FLEX-group. The reduced infectivity of endogenous PCV2 
pools related to single versus multiple vaccinations may reflect PCV2 adaptation to host 
immune responses. That means chronic stimulation with multiple vaccination over 
several sow generations leaves the virus enough time to conquer back the same space 
as without vaccination. The single vaccination treatment might simply be a short time of 
higher immune system pressure on endogenous PCV2 pools. 
It is known for herpes sanctuaries to continuously provide new virus [49]. Compared to 
these we postulate a similar scenario for PCV2 and thymus. For the first time, we could 
show that PCV2 inherently possesses thymus specificity in fetuses from healthy sows. 
Furthermore, we could show PCV2 availability of replicative isoform in thymus. This 
might indicate that PCV2 existence in thymus is based on a low turnover. Thymus 
belongs to the primary lymphatic system and plays an important role in the development 
and differentiation of the immune system in fetuses, neonates and developing pigs. The 
question that immediately comes to mind: what kind of influence have PCV2 infected 
cells in thymus onto the host immune response and the development of PCVAD?  
In conclusion, all fetuses from healthy sows were infected with PCV2 and a vaccination 
of the dams had no influence on the elimination or reduction of PCV2 load in fetuses. 
This was the first time where thymus was investigated systematically and found to be 
the mainly infected organ. On the basis of these results it will be important to continue 
the research about the influence of PCV2 on T-cell development. Failure to detect anti-
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PCV2 antibodies and PCV2 infection before the 57th day of gestation in pig embryos 
and the analogy to CAV infections make it very plausible that PCV2 infects thymus 
latently and uses it also as a sanctuary against immune responses. 
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